top of page

BackTable / VI / Podcast / Episode #310

Intravascular Lithotripsy for Fem-Pop Disease in the ASC

with Dr. Jim Melton and Amanda Stanley

In this episode, host Dr. Aaron Fritts interviews Dr. Jim Melton and Amanda Stanley about intravascular lithotripsy in the ASC, including reimbursement trends, patient selection and the future of the device.

Sponsored by:

Shockwave Medical

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Intravascular Lithotripsy for Fem-Pop Disease in the ASC with Dr. Jim Melton and Amanda Stanley on the BackTable VI Podcast)
Ep 310 Intravascular Lithotripsy for Fem-Pop Disease in the ASC with Dr. Jim Melton and Amanda Stanley
00:00 / 01:04

BackTable, LLC (Producer). (2023, April 10). Ep. 310 – Intravascular Lithotripsy for Fem-Pop Disease in the ASC [Audio podcast]. Retrieved from

BackTable CMEfy button

Stay Up To Date



Sign Up:

Podcast Contributors

Dr. Jim Melton discusses Intravascular Lithotripsy for Fem-Pop Disease in the ASC on the BackTable 310 Podcast

Dr. Jim Melton

Dr. Jim Melton is a practicing Vascular Surgery Specialist in Oklahoma City.

Amanda Stanley, RN, BSN, CNOR discusses Intravascular Lithotripsy for Fem-Pop Disease in the ASC on the BackTable 310 Podcast

Amanda Stanley, RN, BSN, CNOR

Amanda Stanley is the chief operating officer of Advanced CardioVascular Solutions in Oklahoma City.

Dr. Aaron Fritts discusses Intravascular Lithotripsy for Fem-Pop Disease in the ASC on the BackTable 310 Podcast

Dr. Aaron Fritts

Dr. Aaron Fritts is a Co-Founder of BackTable and a practicing interventional radiologist in Dallas, Texas.


We begin by discussing Amanda’s role in the practice. She is an ex OR nurse and has been clinical director for their original hybrid ASC/OBL in Oklahoma City for 8 years. She has taken on many roles over the years, the most recent being COO. Some of her functions under this title include clinical revenue cycle management (RCM), payer negotiation, credentialing and accreditation. Since partnering with a private equity firm, she has also been collaborating with others in ASCs they have acquired around the country.

Dr. Melton states that intravascular lithotripsy (IVL) reimburses very well in the outpatient space, but that this is only true in the ambulatory surgery center (ASC) and does not translate to outpatient based labs (OBLs). Medicare pays for all associated Shockwave intravascular lithotripsy CPT codes, commercial insurance does not. They found in their practice that by using the Medicare fee schedule, they could prove to their local commercial insurance providers that it was worth paying for, and they are now getting it approved via both parties. Specifically, C9765, which is for IVL, percutaneous transluminal angioplasty (PTA) and stenting, pays $5000 more than the code that is just for PTA and stenting.

Lastly, we go over sizing and patient selection. In the ASC, he most commonly uses the 5.5, 6 and 7, which all go through a 5-6 Fr slender sheath in the foot. If you use an 8 then you’ll need a 7 Fr sheath, and if you use a size 9, 10, or 12, you’ll need an 8 Fr sheath. Dr. Melton emphasizes the importance of selecting the right patients for the ASC and hospital. In those with significant comorbidities or a femoral artery that will need a size 9, 10 or 12 balloon, he tends to do these in the hospital. He finds that he places a stent more often than not after IVL and PTA because of what he sees using intravascular ultrasound (IVUS). He shares a tip for using the current IVL balloon. Because it emits the strongest sonic pressure impulse at the center of the balloon, he uses IVUS to mark the most calcified segment, then targets this area with the center of the balloon. He remarks that the newer version, coming out soon, has a shorter balloon and emits the same strength across its entire length, allowing you to skip this step.


Dr. Melton and Amanda Stanley are paid consultants of Shockwave Medical. Opinions expressed are those of the speakers and not necessarily those of Shockwave Medical.

In the United States: Rx only.

Indications for Use—The Shockwave Medical Intravascular Lithotripsy (IVL) System is intended for lithotripsy-enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. Not for use in the coronary, carotid or cerebral vasculature.

Contraindications—Do not use if unable to pass 0.014″ (M5, M5+, S4, E8) or 0.018″ (L6) guidewire across the lesion-Not intended for treatment of in-stent restenosis or in coronary, carotid, or cerebrovascular arteries.

Warnings—Only to be used by physicians who are familiar with interventional vascular procedures—Physicians must be trained prior to use of the device—Use the generator in accordance with recommended settings as stated in the Operator’s Manual.

Precautions—use only the recommended balloon inflation medium—Appropriate anticoagulant therapy should be administered by the physician—Decision regarding use of distal protection should be made based on physician assessment of treatment lesion morphology.

Adverse effects–Possible adverse effects consistent with standard angioplasty include–Access site complications–Allergy to contrast or blood thinner–Arterial bypass surgery—Bleeding complications—Death—Fracture of guidewire or device—Hypertension/Hypotension—Infection/sepsis—Placement of a stent—renal failure—Shock/pulmonary edema—target vessel stenosis or occlusion—Vascular complications. Risks unique to the device and its use—Allergy to catheter material(s)— Device malfunction or failure—Excess heat at target site.

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

Please contact your local Shockwave representative for specific country availability.

Disclaimer: The Materials available on are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Become a BackTable Sponsor

Up Next

Transitioning from Academia to Private OBL Practice with Dr. Jafar Golzarian on the BackTable VI Podcast)
Creative Solutions to OBL Misadventures with Dr. Omar Saleh and Dr. Mike Watts on the BackTable VI Podcast)
OBL or ASC for Your Private Practice? How to Decide with Teri Yates on the BackTable VI Podcast)
Site of Service Differentials with Dr. Michael Cumming on the BackTable VI Podcast)
Pros & Cons of Independence in the OBL with Dr. Mahmood Razavi and Dr. Mark Garcia on the BackTable VI Podcast)
Iliofemoral Stenting: Decision-Making & Best Practices Explored with Dr. Kush Desai and Dr. Steven Abramowitz on the BackTable VI Podcast)



Intravascular Lithotripsy Procedure Prep
Learn about Office-Based Lab (OBL) on BackTable VI
Peripheral Artery Disease Condition Overview
Learn about Reimbursement on BackTable VI

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

bottom of page